Market Tracker

06/28 3:40am ET

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

3.70
Delayed Data
As of Jun 27
 -0.28 / -7.04%
Today’s Change
3.50
Today|||52-Week Range
8.79
-46.61%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close3.98
Today’s open3.96
Day’s range3.66 - 3.96
Volume45,481
Average volume (3 months)42,365
Market cap$53.0M
Dividend yield--
Data as of 4:00pm ET, 06/27/2016

Growth & Valuation

Earnings growth (last year)-49.55%
Earnings growth (this year)+43.37%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+485.21%
P/E ratioNM
Price/Sales6.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GLMDGalmed Pharmaceutica...-0.52-10.90%
NTECIntec Pharma Ltd-0.24-5.23%
AVIRAviragen Therapeutic...0.000.00%
VCELVericel Corp-0.12-5.48%
Data as of 4:00pm ET, 06/27/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$9.7M
Annual profit (last year)-$15.9M
Net profit margin-163.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
Senior Operations Director
Joe Bitterman
Corporate headquarters
San Diego, California

Forecasts